Gene Therapy For Rare Disease Market Size And Share

  • Report Code : TIPRE00003413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

希少疾患向け遺伝子治療市場シェア分析と機会 2025-2031

Buy Now

Gene Therapy For Rare Disease Market Report Gene Therapy For Rare Disease Market Scope and Analysis Gene Therapy For Rare Disease Market Size and Share

Gene Therapy For Rare Disease Market Report Analysis

Gene Therapy For Rare Disease Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BioMarin
  • Orchard Therapeutics plc.
  • Spark Therapeutics, Inc.
  • PTC Therapeutics
  • bluebird bio, Inc.
  • Kite Pharma
  • uniQure N.V.
  • Juno Therapeutics Inc.(Celgene Corporation)
  • Novartis AG

Regional Overview

  • 北米
  • ヨーロッパ
  • アジア太平洋
  • 南米および中米
  • 中東およびアフリカ

Market Segmentation

By 治療への応用
  • 腫瘍学
  • 神経疾患
  • 眼科疾患
  • 血液疾患
  • 免疫不全疾患
  • 代謝疾患
  • その他
By 地理
  • 北アメリカ
  • ヨーロッパ
  • アジア太平洋
  • 南アメリカ
  • 中央アメリカ